Optellum was founded so that every lung cancer patient can get treated at an early stage, when it can be cured. We are applying machine learning technologies on the world's largest clinical dataset, to identify patients at risk of developing lung cancer to ensure they receive the best possible care.
You would work closely with the founders, AI & medical experts from University of Oxford, who have track records of commercializing technology through 10 start-ups (to date 5 trade sales and 1 IPO).
See Careers at http://www.optellum.com/ to join the fight against cancer and improve lives of millions!